InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Beckman Daniella, 董事. Officer active across 2 companies, notably Blueprint Medicines Corp. Aggregated, 12 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €35k. History available since 8 December 2021. The latest transaction was filed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Beckman Daniella is Administrateur at Tango Therapeutics, Inc. and Director at Blueprint Medicines Corp. She has 12 filings in total, and across the recent filings available, the period runs from 2022-03-31 to 2026-02-04, with 0 in buys and 34709 in sells, the most frequent transaction nature being Attribution.